A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD)

Author： Prasad Suyash   Harpin Val   Poole Lynne   Zeitlin Harry   Jamdar Saroj   Puvanendran Kanagasabai    

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.23, Iss.2, 2007-02, pp. : 379-394

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Modafinil in children and adolescents with attention-deficit/hyperactivity disorder: a preliminary 8-week, open-label study

By Boellner Samuel W.   Earl Craig Q.   Arora Sanjay  

Current Medical Research and Opinion, Vol. 22, Iss. 12, 2006-12 ,pp. : 2457-2465

Informa Healthcare

Access to resources Recommend Favorite

Attention deficit hyperactivity disorder (ADHD) in children and adolescents

By  

PROGRESS IN NEUROLOGY AND PSYCHIATRY, Vol. 19, Iss. 3, 2015-05 ,pp. : 16-23

John Wiley & Sons Inc

Access to resources Recommend Favorite

An Open-Label Pilot Study of Homeopathic Treatment of Attention Deficit Hyperactivity Disorder in Children and Youth

By  

Forschende Komplementärmedizin / Research in Complementary Medicine, Vol. 21, Iss. 5, 2014-09 ,pp. : 302-309

Karger

Access to resources Recommend Favorite

Effectiveness of oral tipepidine administration for children with attention deficit/hyperactivity disorder: A 4‐week, open‐label clinical study

By  

PSYCHIATRY AND CLINICAL NEUROSCIENCES, Vol. 69, Iss. 10, 2015-10 ,pp. : 658-659

John Wiley & Sons Inc

Access to resources Recommend Favorite

Atomoxetine in the treatment of children, adolescents and adults with attention deficit hyperactivity disorder

By Turgay Atilla  

Therapy, Vol. 3, Iss. 1, 2006-01 ,pp. : 19-38

Future Medicine

Access to resources Recommend Favorite